Détention brevets de la classe C07D 241/42

Brevets de cette classe: 322

Historique des publications depuis 10 ans

22
23
25
22
27
17
29
19
19
11
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Merck Patent GmbH
5725
19
Neupharma, Inc.
73
17
Vertex Pharmaceuticals Incorporated
1587
8
Otsuka Pharmaceutical Co., Ltd.
1500
5
Bristol-myers Squibb Company
4721
4
F. Hoffmann-La Roche AG
7832
4
Syngenta Crop Protection AG
6668
4
FUJIFILM Corporation
30458
4
Semiconductor Energy Laboratory Co., Ltd.
11775
4
Astex Therapeutics Limited
208
4
Canbas Co., Ltd.
20
4
CHDI Foundation, Inc.
106
4
General Incorporated Association Pharma Valley Project Supporting Organization
18
4
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
178
4
The Scripps Research Institute
1344
4
Takasago International Corporation
405
4
The University of Queensland
661
4
Merck Sharp & Dohme LLC
3728
4
Genentech, Inc.
4101
3
Janssen Pharmaceutica N.V.
3177
3
Autres propriétaires 211